SQZ Biotechnologies Company (SQZB)
USD 0.03
(1.82%)
USD 0.03
(1.82%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Operating Cash Flow | -83.54 Million | -82.13 Million | -43.15 Million | -33.49 Million | 21.09 Million |
| Net Income | -79.46 Million | -68.74 Million | -50.52 Million | -32.2 Million | -20.23 Million |
| Depreciation & Amortization | 11.68 Million | 11.03 Million | 10.94 Million | 4.35 Million | 1.06 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 8.4 Million | 8.5 Million | 3.6 Million | 2.1 Million | - |
| Change in working capital | -24.2 Million | -32.93 Million | -7.27 Million | -6.83 Million | 39.15 Million |
| Other non-cash items | 30.22 Million | 30.6 Million | 25.5 Million | 9.2 Million | 3.17 Million |
| Investing Cash Flow | -488 Thousand | -613 Thousand | 57.82 Million | -12.84 Million | -36.96 Million |
| Investments in PPE | -522 Thousand | -613 Thousand | -1.17 Million | -2.16 Million | -1.3 Million |
| Acquisitions | 34 Thousand | - | - | - | - |
| Investment purchases | - | - | - | -115.88 Million | -74.9 Million |
| Sales/Maturities of investments | - | - | 59 Million | 105.2 Million | 39.25 Million |
| Other Investing Activities | 34 Thousand | - | - | - | - |
| Financing Cash Flow | 4.23 Million | 55.9 Million | 116.41 Million | 26.03 Million | 68.11 Million |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 4.23 Million | 55.9 Million | 116.41 Million | 26.03 Million | 68.11 Million |
| Other Financing Activities | 166 Thousand | 54.49 Million | -1.76 Million | - | - |
| Accounts receivables | 3 Million | -1.1 Million | -18 Thousand | -1 Million | -365 Thousand |
| Accounts payables | -1.42 Million | 1.07 Million | 100 Thousand | 1.7 Million | 434 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | -25.78 Million | -32.9 Million | -7.36 Million | -7.53 Million | 39.08 Million |
| Cash at beginning of period | 143.51 Million | 170.35 Million | 39.25 Million | 59.57 Million | 7.31 Million |
| Cash at end of period | 63.7 Million | 143.51 Million | 170.35 Million | 39.25 Million | 59.57 Million |
| Capital Expenditure | -522 Thousand | -613 Thousand | -1.17 Million | -2.16 Million | -1.3 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -79.8 Million | -26.84 Million | 131.1 Million | -20.31 Million | 52.25 Million |
| Free Cash Flow | -84.07 Million | -82.75 Million | -44.32 Million | -35.65 Million | 19.79 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -23.63 Million | -16.77 Million | -17.68 Million | -13.54 Million | -79.46 Million | -22.64 Million |
| Depreciation & Amortization | 2.22 Million | 2.24 Million | 3.05 Million | 3.39 Million | 11.68 Million | 2.85 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 983 Thousand | 1.15 Million | 695 Thousand | 1.77 Million | 8.4 Million | - |
| Change in working capital | -624 Thousand | -1.78 Million | -9.83 Million | -12.36 Million | -24.2 Million | -4.46 Million |
| Other non-cash items | 11.61 Million | 6.45 Million | 6.82 Million | 9.34 Million | 30.22 Million | 6.42 Million |
| Investing Cash Flow | 15 Thousand | 108 Thousand | -65 Thousand | -101 Thousand | -488 Thousand | -113 Thousand |
| Investments in PPE | - | -47 Thousand | -65 Thousand | -101 Thousand | -522 Thousand | -113 Thousand |
| Acquisitions | 15 Thousand | 155 Thousand | - | - | 34 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 15 Thousand | - | - | - | - | - |
| Financing Cash Flow | - | - | - | 331 Thousand | 4.23 Million | 670 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 331 Thousand | 4.23 Million | 670 Thousand |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | 3 Million | - |
| Accounts payables | 350 Thousand | -922 Thousand | -26 Thousand | -798 Thousand | -1.42 Million | 1.65 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -974 Thousand | -866 Thousand | -9.8 Million | -11.57 Million | -25.78 Million | -6.11 Million |
| Cash at beginning of period | 24.71 Million | 39.87 Million | 63.7 Million | 84.23 Million | 143.51 Million | 105.56 Million |
| Cash at end of period | 10.19 Million | 24.71 Million | 39.87 Million | 63.7 Million | 63.7 Million | 84.23 Million |
| Capital Expenditure | - | -47 Thousand | -65 Thousand | -101 Thousand | -522 Thousand | -113 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -14.51 Million | -15.16 Million | -23.83 Million | -20.53 Million | -79.8 Million | -21.32 Million |
| Free Cash Flow | -14.53 Million | -15.31 Million | -23.83 Million | -20.86 Million | -84.07 Million | -21.99 Million |
JSW
SSYS
VLEEY
ETON
DUST
PDES